DeepMed Research

Uthealth Houston

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1967-01-01

Employees: 11

Market Cap: -

Website: https://www.cizikeyedoctors.org

Clinical Trials

Rescue Quadratus Lumborum Blocks for Post-cesarean Pain

Phase 4

Withdrawn

Conditions: Morphine
Analgesics
Analgesics, Opioid
Peripheral Nervous System Agents

Interventions: Drug: Saline
Drug: Bupivacaine
Drug: Dexamethasone

First Posted Date: 2020-05-21

Last Posted Date: 2023-11-03

Lead Sponsor: The University of Texas Health Science Center, Houston

Registration Number: NCT04397458

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Phase 4

Completed

Conditions: Glucose Intolerance
Overweight and Obesity
Drug Effect
Adiposity

Interventions: Drug: Cyanocobalamin
Drug: Dulaglutide

First Posted Date: 2020-05-13

Last Posted Date: 2024-12-05

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 23

Registration Number: NCT04387201

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Prevention Program to Reduce Injury Disparities Among Latino Day Laborers

Not Applicable

Completed

Conditions: Work-related Injury

Interventions: Behavioral: Control Condition
Behavioral: Motivational Interview (MI)
Behavioral: Participatory Group Activity

First Posted Date: 2020-05-07

Last Posted Date: 2020-05-07

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 75

Registration Number: NCT04378348

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis

Phase 2

Recruiting

Conditions: Adults With Ulcerative Colitis

Interventions: Drug: Placebos
Drug: PRIM-DJ2727

First Posted Date: 2020-05-04

Last Posted Date: 2024-02-06

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 58

Registration Number: NCT04373473

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease

Phase 2

Withdrawn

Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus

Interventions: Drug: PRIM-DJ2727
Drug: Placebo

First Posted Date: 2020-05-01

Last Posted Date: 2024-05-14

Lead Sponsor: The University of Texas Health Science Center, Houston

Registration Number: NCT04371653

Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine

Phase 4

Completed

Conditions: Central Nervous System Depressants
Physiological Effect of Drugs
Analgesics
Analgesics, Opioid
Narcotics
Morphine

Interventions: Drug: 3% 2-chloroprocaine and epidural morphine

First Posted Date: 2020-04-30

Last Posted Date: 2022-05-26

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 44

Registration Number: NCT04369950

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Fabrication of Naso-alveolar Molding (NAM) Appliance in Cleft Lip and Palate (CLP) From Digital Magnetic Resonance Imaging (MRI) Face Scan

Not Applicable

Terminated

Conditions: Cleft Lip and Palate

Interventions: Device: 3D NAM
Device: Traditional NAM

First Posted Date: 2020-04-30

Last Posted Date: 2022-04-11

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 1

Registration Number: NCT04369638

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain

Phase 4

Terminated

Conditions: Pain, Postoperative

Interventions: Drug: Intrathecal morphine sulfate (ITM)
Drug: Bupivacaine hydrochloride
Drug: ropivacaine hydrochloride

First Posted Date: 2020-04-29

Last Posted Date: 2022-05-16

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 3

Registration Number: NCT04368364

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
🇺🇸
Memorial Hermann Hospital TMC, Houston, Texas, United States

Utilizing Activity Trackers to Promote Physical Activity in People With Epilepsy: Can we Make a Difference?

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Behavioral: Standard of Care Group
Behavioral: Activity Tracker Group

First Posted Date: 2020-04-22

Last Posted Date: 2023-12-05

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 80

Registration Number: NCT04357912

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Patient Centered Outcomes Study

Not Applicable

Completed

Conditions: Hernia, Ventral

Interventions: Behavioral: Disclosure timing

First Posted Date: 2020-04-21

Last Posted Date: 2023-06-23

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 500

Registration Number: NCT04355819

Locations: 🇺🇸
Lyndon B. Johnson General Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy